No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 1.3600
- -0.0300-2.16%
Close Apr 19 16:00 ET
- 1.3600
- 0.00000.00%
Post 19:57 ET
284.75MMarket Cap-4857P/E (TTM)
1.3800High1.3100Low2.96MVolume1.3500Open1.3900Pre Close3.96MTurnover1.56%Turnover RatioLossP/E (Static)209.37MShares2.480052wk High-9.32P/B257.20MFloat Cap0.650052wk Low--Dividend TTM189.12MShs Float31.0000Historical High--Div YieldTTM5.04%Amplitude0.2410Historical Low1.3400Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Akebia Therapeutics Inc: on April 15, Company and Sta Entered Into Amendment #2 to Supply Agreement
Express News | Akebia Therapeutics Inc - Amendment Amends the Volume-Based Pricing Structure Under the Supply Agreement
Express News | Akebia Therapeutics Inc - Term of Supply Agreement Is Extended for an Additional Five Years and Expires on April 2, 2029
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersIN8bio (NASDAQ:INAB) stock increased by 47.7% to $1.61 during Wednesday's pre-market session. The market value of their outstanding shares is at $69.6 million. Jaguar Health (NASDAQ:JAGX) share
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAvalo Therapeutics (NASDAQ:AVTX) shares increased by 364.8% to $22.08 during Friday's regular session. The market value of their outstanding shares is at $17.6 million. Nexalin Technology (NASD
Comments
Update
$Akebia Therapeutics(AKBA.US$ Akebia Therapeutics Inc - Term of Supply Agreement Is Extended for an Additional Five Years and Expires on April 2, 2029
4
11
Biotech Stocks: Price Action and Logic
I have noticed recently that some shares despite FDA approval, price action is opposite, also earning call sometimes when it beats estimates projection, the market sentiment or price action is in reverse.
Which is more important when picking a trade:
Earning or FDA outcome
Acquisition or Market sentiment
Happy to learn from friends here.
$Enlivex Therapeutics(ENLV.US$
$Akebia Therapeutics(AKBA.US$
$Rekor Systems(REKR.US$
$OncoCyte(OCX.US$
Which is more important when picking a trade:
Earning or FDA outcome
Acquisition or Market sentiment
Happy to learn from friends here.
$Enlivex Therapeutics(ENLV.US$
$Akebia Therapeutics(AKBA.US$
$Rekor Systems(REKR.US$
$OncoCyte(OCX.US$
1
2
$Akebia Therapeutics(AKBA.US$ monday will 🚀??
1
$Akebia Therapeutics(AKBA.US$ if it breaks 1.95🚀🚀🚀
1
1
$Akebia Therapeutics(AKBA.US$ Bullish engulfing candle on yesterday’s daily! Which held up today! Looking now for trend to continue, at least short term? NFA just thinking outloud 
3
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
amiable Llama_6295 : Hcw target price is $6
TrytosaveabitOP amiable Llama_6295: Yeah! I thank you for sharing! GL and big profits to ya!
amiable Llama_6295 TrytosaveabitOP:
amiable Llama_6295 : sold some to buy meli one of my
TrytosaveabitOP amiable Llama_6295: Very nice! But that’s a bit high for me to day trade it! Hehehe! But I hope you do great in MELI
View more comments...